Pregnancy testing for women of childbearing age, repeated monthly during treatment per the REMS program
However, there is currently a significant gap in research on the microbiota-associated metabolism of GRP/SFN
How will your team distinguish between medication side effects and Crohn's disease activity
Metseras portfolio includes: injectable GLP-1 receptor agonist MET-097i (phase 2), amylin analog candidate MET-233i (phase I), two oral GLP-1 RA candidates expected to begin clinical trials imminently, and additional preclinical nutrient-stimulated hormone therapeutics
This expertise, coupled with ongoing advancements in battery technology, allows us to develop robust, efficient, and safe power solutions for a wide array of applications
There's no way I could keep up with toddlers in the shape I'd been in!" First For Women aims to feature only the best products and services